Becarbon (Tablets) Instructions for Use

Marketing Authorization Holder

Tatkhimpharmpreparaty, JSC (Russia)

ATC Code

A03BA04 (Total belladonna alkaloids)

Active Substances

Sodium bicarbonate (BP British Pharmacopoeia)

Belladonna (Ph.Eur. European Pharmacopoeia)

Dosage Form

Becarbon

Tablets 10 mg+300 mg: 6, 10, 12, 18, 20, or 30 pcs.

Dosage Form, Packaging, and Composition

6 pcs. – non-blister contour packs.
6 pcs. – non-blister contour packs (2) – cardboard packs.
6 pcs. – non-blister contour packs (3) – cardboard packs.
6 pcs. – non-blister contour packs (5) – cardboard packs.
10 pcs. – non-blister contour packs.
10 pcs. – non-blister contour packs (2) – cardboard packs.

Clinical-Pharmacological Group

Drug with antispasmodic (m-cholinoblocking) and antacid action

Pharmacotherapeutic Group

Spasmolytic agent

Pharmacological Action

Combined medicinal product for oral administration. It has antispasmodic and antacid action.

Belladonna leaf extract has an antispasmodic (m-cholinoblocking) effect. It prevents the stimulating action of acetylcholine; reduces the secretion of salivary, gastric, bronchial, lacrimal, sweat glands, and the pancreas. It reduces the tone of the muscles of the gastrointestinal tract, bile ducts, and gallbladder; causes tachycardia, improves AV conduction.

Sodium bicarbonate when taken orally interacts with hydrochloric acid of gastric juice, neutralizing it. It increases the excretion of sodium and chloride, osmotic diuresis.

Indications

Intestinal colic; hyperacid gastritis; heartburn; dyspepsia.

ICD codes

Dosage Regimen

Take orally, 30-40 minutes before meals.

Administer 1 tablet as a single dose, 2-3 times per day.

Adhere to a maximum daily dose of 15 tablets for adults.

Do not exceed the recommended dosage.

Consult a physician if symptoms persist or for use beyond several days.

Adverse Reactions

Possible dry mouth, thirst, intestinal atony, urinary retention, tachycardia, mydriasis, accommodation paresis.

Contraindications

Angle-closure glaucoma; prostatic hypertrophy with impaired urine outflow; hypersensitivity to the components of the medicinal product.

Special Precautions

In case of overdose, psychomotor agitation, convulsions, accommodation paresis, acute urinary retention are possible.

Effect on ability to drive vehicles and mechanisms

During the treatment period, caution should be exercised when driving vehicles and engaging in other potentially hazardous activities that require increased concentration, speed of psychomotor reactions, and good vision.

Drug Interactions

With simultaneous use with m-cholinoblockers, enhancement of the m-cholinoblocking action is possible.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.